JOSD2 and neoplasm: Similarly, on a pre-existing NCI-H1299 tumor models, intratumor injection of lentiviral vector delivering JOSD2 shRNA exhibited significant suppressive effect on the tumor growth, with inhibition ratio as 59.72% (P < 0.001) (Fig. 1j–k and Supplementary Fig. S2e).